US Broker Ratings

Chevron Corporation (CVX) Investor Outlook: Navigating Growth with a 3.83% Dividend Yield

Chevron Corporation (NYSE: CVX), a titan in the global energy sector, stands tall with a market capitalization of $371.52 billion. Known for its comprehensive operations in the oil and gas..

Aurora Cannabis Inc. (ACB) Stock Analysis: Exploring an 86.95% Potential Upside

Aurora Cannabis Inc. (NYSE: ACB) continues to be a focal point for investors eyeing the burgeoning cannabis sector. With its diverse portfolio and international reach, Aurora offers a compelling narrative..

Spok Holdings, Inc. (SPOK) Stock Analysis: Navigating a 55.67% Potential Upside Amid High Dividend Yield

Spok Holdings, Inc. (NASDAQ: SPOK), a key player in the healthcare communication solutions sector, presents a unique blend of stability and opportunity for investors seeking exposure to the health information..

Outset Medical, Inc. (OM)

⚠️ No article content returned.

..

Alpha Teknova, Inc. (TKNO) Stock Analysis: Exploring a 326% Potential Upside in the Healthcare Sector

Alpha Teknova, Inc. (NASDAQ: TKNO) stands as a noteworthy player in the healthcare sector, specifically within the drug manufacturing industry, focusing on specialty and generic products. With a market capitalization..

Varex Imaging Corporation (VREX) Stock Analysis: Exploring a 32% Upside Potential

Varex Imaging Corporation (NASDAQ: VREX), a key player in the healthcare sector specializing in medical devices, presents an intriguing investment opportunity with a potential upside of 32.26%. The company, headquartered..

TruBridge, Inc. (TBRG) Investor Outlook: A Glimpse Into a Potential 21.60% Upside

TruBridge, Inc. (NASDAQ: TBRG), a prominent player in the healthcare sector, operates within the health information services industry, providing critical solutions to enhance financial health and patient care for healthcare..

ClearPoint Neuro Inc. (CLPT): Investor Outlook Reveals 116.90% Potential Upside in Medical Devices Sector

ClearPoint Neuro Inc. (NASDAQ: CLPT), a pioneering player in the healthcare sector’s medical devices industry, is capturing investor attention with its impressive potential upside of 116.90%. Specializing in minimally invasive..

Wave Life Sciences Ltd. (WVE) Stock Analysis: A Biotech with 145% Upside Potential

Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology company based in Singapore, is capturing the attention of investors with its innovative approach to RNA medicine. With a market capitalization..

The Pennant Group, Inc. (PNTG) Stock Report: A Promising 21.75% Upside for Healthcare Investors

The Pennant Group, Inc. (NASDAQ: PNTG) is emerging as a compelling opportunity for investors within the healthcare sector. With a robust market capitalization of $1.07 billion, this Idaho-based company operates..

Dynavax Technologies Corporation (DVAX) Stock Analysis: Exploring a 41.94% Potential Upside

Dynavax Technologies Corporation (NASDAQ: DVAX) is garnering attention in the healthcare sector, particularly among investors eyeing its promising potential upside. With a market capitalization of $1.82 billion, this biopharmaceutical company..

Harrow, Inc. (HROW) Stock Analysis: A 48% Upside in the Promising Ophthalmic Pharmaceuticals Sector

Harrow, Inc. (NASDAQ: HROW), a noteworthy entity in the healthcare sector, is capturing investor attention with a formidable 48.81% potential upside. Specializing in the development and commercialization of ophthalmic pharmaceutical..

Vera Therapeutics, Inc. (VERA) Stock Analysis: A 71% Upside Potential in the Biotech Arena

In the dynamic world of biotechnology, Vera Therapeutics, Inc. (NASDAQ: VERA) emerges as a compelling player with significant upside potential. With a market capitalization of $3.11 billion, the California-based company..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring a 10.35% Potential Upside

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a key player in the healthcare sector, has attracted attention for its promising potential upside of 10.35%. Specializing in both generic and proprietary injectable, inhalation,..

Guardian Pharmacy Services, Inc (GRDN): Stock Analysis Reveals 2.67% Potential Upside Amid Robust Revenue Growth

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN) has garnered significant attention from investors, positioning itself as a noteworthy player in the healthcare sector, specifically within medical care facilities. With a market..

Liquidia Corporation (LQDA) Stock Analysis: Exploring a 1,121% Revenue Surge in Biotech

Liquidia Corporation (NASDAQ: LQDA), a pioneering entity in the biotechnology sector, has recently captured the attention of investors with its remarkable revenue growth, reaching an astonishing 1,121.70%. This surge highlights..

AdaptHealth Corp. (AHCO) Stock Analysis: Exploring a 24.77% Upside Potential in the Medical Devices Sector

For investors seeking opportunities in the healthcare sector, AdaptHealth Corp. (NASDAQ: AHCO) presents a compelling case. As a prominent player in the medical devices industry, AdaptHealth specializes in the distribution..

Omnicell, Inc. (OMCL) Stock Analysis: Unpacking a Potential 57% Upside in Healthcare Automation

Omnicell, Inc. (NASDAQ: OMCL) is an intriguing player in the healthcare sector, particularly within the health information services industry. Known for providing medication management solutions and adherence tools, Omnicell’s innovative..

10x Genomics, Inc. (TXG) Stock Analysis: Navigating Market Challenges with Cutting-Edge Genomics Technology

10x Genomics, Inc. (NASDAQ: TXG), a prominent player in the healthcare sector, particularly in health information services, offers investors a fascinating case study in the intersection of cutting-edge technology and..

NeoGenomics, Inc. (NEO) Stock Analysis: Healthcare Diagnostics Firm with 27% Potential Upside

NeoGenomics, Inc. (NASDAQ: NEO) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With its headquarters in Fort Myers, Florida, NeoGenomics has carved out..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds